Atlas Trials

Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy

Clinical trial NCT07528586 · RECRUITING

Trial details

NCT number
NCT07528586
Sponsor
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CardiotoxicityAnthracycline-induced Cardiotoxicity
Start date
2026-03-04
Primary completion
2029-08-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.